Fri Sep 13 10:56:00 UTC 2024: ## COPD Cases Expected to Rise in Developed Markets

**Dublin, Sept. 13, 2024** – A new report from ResearchAndMarkets.com predicts a rise in chronic obstructive pulmonary disease (COPD) cases across seven major developed markets (7MM) by 2033.

The report, titled “Chronic Obstructive Pulmonary Disease (COPD): Epidemiology Forecast to 2033,” forecasts that the total prevalent cases of COPD in the 7MM will increase from 62.5 million in 2023 to 70.4 million in 2033, representing an annual growth rate of 1.25%.

The US is projected to have the highest number of COPD cases in the 7MM, with 32.3 million cases in 2033. The UK is expected to have the lowest number of cases, with 3.1 million.

The report also predicts an increase in diagnosed prevalent cases of COPD, rising from 33.7 million in 2023 to 38 million in 2033. Again, the US is expected to have the highest number of diagnosed cases, with 17.9 million in 2033, while Spain is expected to have the fewest diagnosed cases, with 1.2 million.

The report’s analysts attribute the projected increase in COPD cases to changing population dynamics and rising prevalence rates in each of the 7MM countries.

The report provides detailed data on the prevalence of COPD, including diagnosed cases by severity level, age, and gender, as well as an analysis of the impact of COVID-19 on the disease. It also highlights the strengths and limitations of the analysis.

For further information on the report, visit https://www.researchandmarkets.com/r/wf5sbo.

Read More